首页 正文

Estimating the Value of Ensifentrine in Addition to Background Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease

{{output}}
Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases, leading to increased healthcare use, expenditures, and risk of mortality. In June 2024, the Institute for Clinical and Economic Review (ICER) released a traditional cost-effe... ...